
Second-generation antiandrogens
Loading player...
We learn about new treatment options for advanced prostate cancer: second-generation antiandrogens
Prof Shingai Mutambirwa is the Head of Urology at Sefako Makgatho Health Sciences University as well as the Chairman of the Academic Committee of the South African Urological Association and Head of the Medical and Scientific Advisory Board of The Prostate Cancer Foundation of South Africa.
Andrew Oberholzer is the CEO of The Prostate Cancer Foundation of South Africa.
Prof Shingai Mutambirwa is the Head of Urology at Sefako Makgatho Health Sciences University as well as the Chairman of the Academic Committee of the South African Urological Association and Head of the Medical and Scientific Advisory Board of The Prostate Cancer Foundation of South Africa.
Andrew Oberholzer is the CEO of The Prostate Cancer Foundation of South Africa.